Description

PT-141 (10mg)

PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.

Chemical Formula: C50H68N14O10
Molecular Mass: 1025.2
Synonyms: Bremelanotide, Vyleesi, CHEMBL2070241
CAS Number: 189691-06-3
Total Amount of the Active Ingredient: 10mg (1 vial)
Shelf Life: 36 months

Product Quality

Lab tests are occasionally published on the website.

You can have the product you bought from us tested at any HPLC licensed testing facility and if the results are negative, we will refund the following:

- Cost of HPLC test
- Total amount of the order + shipping fee

Benefits of PT-141

PT-141 is a melanocortin receptor agonist that is FDA-approved to treat female sexual desire disorder, a cluster of symptoms that affects about 10% of women. PT-141 is also an effective ED treatment option that boosts libido in men with and without ED, regardless of whether the cause of ED is physical or psychological.

Increased Libido
Increased Sexual Arousal
Better Erectile Function

Dosage

Typical research dosage: 0.5 mg to 2 mg per administration, depending on study design and experimental model. Recommend Dosage is 1.75mg. It should be administered approximately 45 minutes before sexual activity is expected. PT-141 response times vary from a few minutes to several hours and have been reported to be effective for up to 72 hours.